End-of-life care accounts for a significant proportion of all health spending. Extensive efforts have been made to minimize that spending, which is often futile. A Research Letter in JAMA Internal Medicine analyzes recent trends in Medicare spending in regard to end-of-life care. (JAMA Int. Med. Art.) The researchers used Medicare fee-for-service data from 2004 to 2014 and looked at total average annual spending for all beneficiaries and for beneficiaries who had chronic conditions and died, comparing spending for those who continued to live and those who died. Spending in the two years prior to death was considered end-of-life spending; that seems like a long period. Over 4% of Medicare beneficiaries die each year. Overall per capita Medicare FFS expenditures per beneficiary per year increased between 2004 and 2009 from $9119 to $10,458; and decreased from 2009 to 2014 to $9589; which may reflect the influx of younger baby-boomers. Changes in practice intensity (the number of services for an episode) increased up to 2009, but then decreased. Most of the decrease, 55%, was attributable to decedents, even though they were only a little over 4% of all beneficiaries. The changes in spending occurred among inpatient, home health and physician services. The results suggest that in fact there have been significant results from efforts to control costs and utilization near end-of-life, which is good news for Medicare, which bears most of those costs. It would be interesting to see a comparison with Medicare Advantage, where there is even more incentive to manage spending carefully, and to ascertain if there are some spillover effects, especially among doctors with large MA patient pools.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Best Buy is another large corporation trying to make a bet on health care, in this case largely by providing remote patient monitoring services. The company made yet another significant...
October 13, 2021
Just so men don’t feel left out, a company called Numan has raised $40 million for an app, yada, yada, yada, helping men with ED and other health issues. Also...
October 11, 2021
Money streams in to Flo, which sells an app for women to track menstrual cycles, etc. Investors hope they won’t be left up a creek. $100 million in financing that...
October 11, 2021
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace